GlassScriptPhysician profile
Benita L Bonser
NPI 1285645671
$1,924.46
in general payments reported to CMS, 2019-2025
31 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $69.88 · 2021: $301 · 2022: $530 · 2023: $225 · 2024: $326 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.01 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $517.50 | 2019-2024 | Liletta, Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $342.46 | 2019-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $98.54 | 2021-2024 | |
| Organon LLC | $91.39 | 2021-2025 | Nexplanon |
| Amgen INC. | $73.68 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $72.95 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $60.59 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $56.66 | 2024-2025 | Myfembree |
| Meditrina | $49.53 | 2022-2024 | |
| Hologic Sales and Service, LLC | $48.29 | 2022-2024 | Aptima, Acessa Provu System |
| Biogen, INC. | $45.10 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $44.77 | 2021-2022 | |
| Scynexis, INC. | $44.03 | 2022 | |
| Agile Therapeutics, INC. | $42.16 | 2022-2024 | Twirla |
| Abbott Laboratories | $36.84 | 2025 | Eterna |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $33.28 | 2021-2022 | |
| Coopersurgical, INC. | $30.46 | 2019 | |
| Daiichi Sankyo INC. | $26.76 | 2019 | |
| Optumhealth Care Solutions, LLC | $21.17 | 2023 | Vivify Health Care Team Portal |
| Duchesnay USA Incorporated | $20.53 | 2019 | |
| Applied Medical Resources Corporation | $20.31 | 2023 | |
| Radius Health, INC. | $19.42 | 2020 | |
| Boston Scientific Corporation | $18.34 | 2022 | |
| Medline Industries LP | $17.78 | 2024 | |
| Smith+Nephew, INC. | $15.87 | 2025 | Pico 14 |
| Mylan Pharmaceuticals INC. | $15.33 | 2021 | |
| Merck Sharp & Dohme LLC | $14.43 | 2025 | Gardasil 9 |
| Channel Medsystems, INC. | $12.19 | 2024 | |
| Allergan, INC. | $12.11 | 2020 | |
| Avion Pharmaceuticals | $11.01 | 2019 | |
| Convatec INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benita Bonser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.